Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ocumension Therapeutics | 5DG | Jun 13, 2024 | 0.76 | -1.31 |
Oncimmune Holdings plc | OCY | Jun 13, 2024 | 0.12 | -4.69 |
Oncoarendi Therapeutics SA | 1B1 | Jun 13, 2024 | 3.15 | -1.25 |
Oncotherpapy Science Inc | 30O | Jun 13, 2024 | 0.17 | +36.80 |
Open Orphan plc | CRO | Jun 13, 2024 | 0.31 | +2.61 |
Opthea Limited | UKJ | Jun 13, 2024 | 0.27 | 0.00 |
OptiBiotix Health plc | OB3 | Jun 13, 2024 | 0.19 | +0.53 |
Oric Pharmaceuticals, Inc. | 4TZ | Jun 13, 2024 | 7.05 | -4.08 |
Oxford BioDynamics plc | LMQ | Jun 13, 2024 | 0.05 | +4.04 |
Oxford Biomedica | OXOA | Jun 13, 2024 | 3.60 | -2.70 |
Pharmaron Beijing Co Ltd | 17Q1 | Jun 13, 2024 | 1.13 | -0.88 |
Pharmaust Ltd. | ECQ | Jun 13, 2024 | 0.14 | -0.74 |
Philogen S.p.a. | 78Q | Jun 13, 2024 | 21.70 | 0.00 |
Physiomics | RVW1 | Jun 13, 2024 | 0.01 | +5.26 |
Polynovo Limited | MFJ | Jun 13, 2024 | 1.50 | +10.29 |
Poseida Therapeutics, Inc. | 2RZ | Jun 13, 2024 | 2.57 | +2.07 |
Pure Biologics S A | PQB | Jun 13, 2024 | 1.29 | +2.72 |
PureTech Health Plc | 0VQ | Jun 13, 2024 | 2.62 | 0.00 |
Quantum Genomics | 2QG | Jun 13, 2024 | 0.10 | +4.63 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | Jun 13, 2024 | 0.31 | -0.64 |
RemeGen Co. Ltd. | REG | Jun 13, 2024 | 3.14 | +2.61 |
ReproCELL Incorporated | 6RC | Jun 13, 2024 | 0.62 | -1.59 |
Ryvu Therapeutics S.A. | 9Y4 | Jun 13, 2024 | 12.06 | +1.17 |
Sareum Holdings Plc | RYH0 | Jun 13, 2024 | 0.44 | 0.00 |
Scancell Hldgs Plc | SCP | Jun 13, 2024 | 0.10 | +24.18 |
Sensorion | RFM | Jun 13, 2024 | 0.72 | 0.00 |
Shanghai Haohai Biological Technology Co. Ltd | 5HB | Jun 13, 2024 | 3.42 | -1.16 |
Silence Therapeutics Plc - American Depository Share | XRP2 | Jun 13, 2024 | 18.20 | -1.09 |
Simcere Pharmaceutical Group Limited | S2P | Jun 13, 2024 | 0.67 | -0.74 |
SINO BIOPHARM | SMZ1 | Jun 13, 2024 | 0.32 | -4.99 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.